Report for Lowe V

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (6)

Title : Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration - Kantarci_2022_Brain.Commun_4_fcac013
Author(s) : Kantarci K , Nedelska Z , Chen Q , Senjem ML , Schwarz CG , Gunter JL , Przybelski SA , Lesnick TG , Kremers WK , Fields JA , Graff-Radford J , Savica R , Jones D , Botha H , Knopman DS , Lowe V , Graff-Radford NR , Murray MM , Dickson DW , Reichard RR , Jack CR, Jr. , Petersen RC , Ferman TJ , Boeve BF
Ref : Brain Commun , 4 :fcac013 , 2022
Abstract : Kantarci_2022_Brain.Commun_4_fcac013
ESTHER : Kantarci_2022_Brain.Commun_4_fcac013
PubMedSearch : Kantarci_2022_Brain.Commun_4_fcac013
PubMedID: 35415608

Title : Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies - Graff-Radford_2012_Brain_135_2470
Author(s) : Graff-Radford J , Boeve BF , Pedraza O , Ferman TJ , Przybelski S , Lesnick TG , Vemuri P , Senjem ML , Smith GE , Knopman DS , Lowe V , Jack CR, Jr. , Petersen RC , Kantarci K
Ref : Brain , 135 :2470 , 2012
Abstract : Graff-Radford_2012_Brain_135_2470
ESTHER : Graff-Radford_2012_Brain_135_2470
PubMedSearch : Graff-Radford_2012_Brain_135_2470
PubMedID: 22810436

Title : Autoimmune dementia: clinical course and predictors of immunotherapy response - Flanagan_2010_Mayo.Clin.Proc_85_881
Author(s) : Flanagan EP , McKeon A , Lennon VA , Boeve BF , Trenerry MR , Tan KM , Drubach DA , Josephs KA , Britton JW , Mandrekar JN , Lowe V , Parisi JE , Pittock SJ
Ref : Mayo Clin Proc , 85 :881 , 2010
Abstract : Flanagan_2010_Mayo.Clin.Proc_85_881
ESTHER : Flanagan_2010_Mayo.Clin.Proc_85_881
PubMedSearch : Flanagan_2010_Mayo.Clin.Proc_85_881
PubMedID: 20884824

Title : Stereoselective antimuscarinic effects of 3-quinuclidinyl atrolactate and 3-quinuclidinyl xanthene-9-carboxylate - Noronha-Blob_1992_Eur.J.Pharmacol_211_97
Author(s) : Noronha-Blob L , Sturm B , Lowe V
Ref : European Journal of Pharmacology , 211 :97 , 1992
Abstract : Noronha-Blob_1992_Eur.J.Pharmacol_211_97
ESTHER : Noronha-Blob_1992_Eur.J.Pharmacol_211_97
PubMedSearch : Noronha-Blob_1992_Eur.J.Pharmacol_211_97
PubMedID: 1618272

Title : Muscarinic receptors: relationships among phosphoinositide breakdown, adenylate cyclase inhibition, in vitro detrusor muscle contractions and in vivo cystometrogram studies in guinea pig bladder - Noronha-Blob_1989_J.Pharmacol.Exp.Ther_249_843
Author(s) : Noronha-Blob L , Lowe V , Patton A , Canning B , Costello D , Kinnier WJ
Ref : Journal of Pharmacology & Experimental Therapeutics , 249 :843 , 1989
Abstract : Noronha-Blob_1989_J.Pharmacol.Exp.Ther_249_843
ESTHER : Noronha-Blob_1989_J.Pharmacol.Exp.Ther_249_843
PubMedSearch : Noronha-Blob_1989_J.Pharmacol.Exp.Ther_249_843
PubMedID: 2543813

Title : Poster: Potent and selective muscarinic (M1) antagonists -
Author(s) : Noronha-Blob L , Ferkany J , Costello D , Lowe V , Rzeszotarski W , Kinnier WJ , U'Prichard DC
Ref : Trends in Pharmacological Sciences , Suppl :84 , 1986
PubMedID: